Insilico Medicine Launches AI-Driven 'Longevity Vaccines' Program
rand_longevity · x · 2026-09-19
AI drug discovery company Insilico Medicine has announced a research program called "Longevity Vaccines," aiming to use AI to develop therapeutic vaccines against aging itself. Details of the approach are laid out in the company's materials.
Related event: Insilico Medicine Launches AI-Driven Longevity Vaccine Program(2 posts)→
More from Apps
- Holberton co-founder's free AI course wraps week 1, teaching learners to distrust chatbot answers — jbarbier · 2026-09-19
- Notion's Muse Can Now Connect to Notion, Auto-Find Context and Update Docs — armand_ruiz · 2026-09-19
- Energy agent can log you in and pay with your card, credentials stay local — emilahlback · 2026-09-19
- Hippocratic AI CEO: best healthcare AI use cases are ones nobody thought to do — julesyoo · 2026-09-19
- CoreAI Zoo hits App Store: run Qwen, Gemma and more fully on-device on iPhone — pcuenq · 2026-09-19
- Community Notes rolls out globally, notes now appear a median 2.8 hours faster — NathanpmYoung · 2026-09-19